Brief: Predictive Oncology Announces Progress With FluGen In Development Of First-Of-Its-Kind Intranasal Flu Vaccine
30/04/2024 21:42
April 30 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY ANNOUNCES SIGNIFICANT PROGRESS WITH
FLUGEN
IN THE DEVELOPMENT OF FIRST-OF-ITS-KIND INTRANASAL FLU VACCINE
Source text for Eikon: ID:nGNX96lqh9
Further company coverage: POAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces $25.9 Million In Contracts Across Two Long-Term Agreements
Brief: Axe Compute - Discloses Updated Risk Factors On Gpu Infrastructure Expansion - SEC Filing
Axe Compute Q1 revenue falls as legacy sales decline, net loss widens
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM